@Article{M-10263,
AUTHOR = {Adam, Lulu and Tenga, Walter},
TITLE = {Quelling HIV: Enduring Antiretroviral Potency Amidst Initial Viremia and Its Absence},
JOURNAL = {Scientific Research Journal of Medical and Health Science},
VOLUME = {3},
YEAR = {2025},
NUMBER = {2},
ARTICLE-NUMBER = {M-10263},
URL = {https://isrdo.org/journal/SRJMH/currentissue/quelling-hiv-enduring-antiretroviral-potency-amidst-initial-viremia-and-its-absence},
ISSN = {2584-1521},
ABSTRACT = {When it comes to viremia, or measurable viral levels in the bloodstream, the Human Immunodeficiency Virus (HIV) remains a major concern for world health. Despite the revolutionary impact of antiretroviral medication (ART), obstacles to adherence, viral reservoirs, and resistant virus strains continue to pose a threat to HIV treatment. Whether or not initial viremia is present, this article investigates the long-term efficacy of antiretroviral therapy. Our research delves at the inner workings of the virus, how long-acting antiretroviral therapy (ART) affects patients, and possible approaches to attaining long-term viral suppression. Examining the current literature critically reveals new information on viral reservoirs, medicines that improve adherence, and changing treatment paradigms.},
DOI = {}
}